The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Stereotactic body radiotherapy for multisite extracranial oligometastases: Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
Abstract
BACKGROUND: A subset of patients with metastatic cancer in limited organs may benefit from metastasis‐directed therapy. The authors investigated whether patients with limited metastases could be safely treated with metastasis‐directed radiotherapy. METHODS: Patients with 1 to 5 metastatic cancer sites with a life expectancy of >3 months received escalating stereotactic body radiotherapy (SBRT) doses to all known cancer sites. Patients were followed radiographically with CT scans of the chest, abdomen, and pelvis and metabolically with fluorodeoxyglucose‐positron emission tomography, 1 month after treatment, and then every 3 months. Acute toxicities were scored using the National Cancer Institute's Common Terminology Criteria for Adverse Events version 3.0, and late toxicities were scored using the Radiation Therapy Oncology Group late toxicity scoring system. RESULTS: Sixty‐one patients with 113 metastases were enrolled from November 2004 to November 2009 on a prospective radiation dose escalation study. Median follow‐up was 20.9 months. Patients tolerated treatment well; the maximal tolerated dose was not reached in any cohort. Eleven patients (18.3%) have not progressed. One and 2‐year progression‐free survival are 33.3% (95% confidence interval [CI], 22.8‐46.1) and 22.0% (95% CI, 12.8‐34.4); 1‐year and 2‐year overall survival are 81.5% (95% CI, 71.1‐91.1) and 56.7% (95% CI, 43.9‐68.9). Seventy‐two percent of patients whose tumors progressed did so in limited (1‐3) metastatic sites. CONCLUSIONS: Patients with 1 to 5 metastases can be safely treated to multiple body sites and may benefit from SBRT. Further investigation should focus on patient selection. Cancer 2011;. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Cox, J. D., Stetz, J., & Pajak, T. F. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00060-c · Cited by 4,792
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., Macdonald, J. S., & Young, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002223220802 · Cited by 3,135
TROTTI, A., COLEVAS, A., SETSER, A., RUSCH, V, JAQUES, D., BUDACH, V, LANGER, C., MURPHY, B., CUMBERLIN, R., & COLEMAN, C. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00031-6 · Cited by 2,569
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Self-citationStereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Timmerman, R. (2010) · JAMA · doi:10.1001/jama.2010.261 · Cited by 2,532
Andrews, D. W., Scott, C. B., Sperduto, P. W., Flanders, A. E., Gaspar, L. E., Schell, M. C., Werner-Wasik, M., Demas, W., Ryu, J., Bahary, J.-P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16250-8 · Cited by 2,417
Patchell, R. A., Tibbs, P. A., Regine, W. F., Payne, R., Saris, S., Kryscio, R. J., Mohiuddin, M., & Young, B. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66954-1 · Cited by 2,388
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
Timmerman, R., McGarry, R., Yiannoutsos, C., Papiez, L., Tudor, K., DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5937 · Cited by 1,556
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases
Pastorino, U., Buyse, M., Friedel, G., Ginsberg, R. J., Girard, P., Goldstraw, P., Johnston, M., McCormack, P., Pass, H., & Putnam, J. B. (1997) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(97)70397-0 · Cited by 1,529
Liver resection for colorectal metastases.
Fong, Y., Cohen, A. M., Fortner, J. G., Enker, W. E., Turnbull, A. D., Coit, D. G., Marrero, A. M., Prasad, M., Blumgart, L. H., & Brennan, M. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.938 · Cited by 1,284
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Rusthoven, K. E., Kavanagh, B. D., Burri, S. H., Chen, C., Cardenes, H., Chidel, M. A., Pugh, T. J., Kane, M., Gaspar, L. E., & Schefter, T. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6386 · Cited by 1,082
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Rusthoven, K. E., Kavanagh, B. D., Cardenes, H., Stieber, V. W., Burri, S. H., Feigenberg, S. J., Chidel, M. A., Pugh, T. J., Franklin, W., Kane, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6329 · Cited by 805
Extracranial Stereotactic Radioablation *
Timmerman, R., Papiez, L., McGarry, R., Likes, L., DesRosiers, C., Frost, S., & Williams, M. (2003) · Chest · doi:10.1378/chest.124.5.1946 · Cited by 671
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases
Schefter, T. E., Kavanagh, B. D., Timmerman, R. D., Cardenes, H. R., Baron, A., & Gaspar, L. E. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.002 · Cited by 436
Solitary Colorectal Liver Metastasis: Resection Determines Outcome
Aloia, T. A. (2006) · Archives of Surgery · doi:10.1001/archsurg.141.5.460 · Cited by 432
Phase II study on stereotactic body radiotherapy of colorectal metastases
Hoyer, M., Roed, H., Traberg Hansen, A., Ohlhuis, L., Petersen, J., Nellemann, H., Kiil Berthelsen, A., Grau, C., Aage Engelholm, S., & Von Der Maase, H. (2006) · Acta Oncologica · doi:10.1080/02841860600904854 · Cited by 426
Tanvetyanon, T., Robinson, L. A., Schell, M. J., Strong, V. E., Kapoor, R., Coit, D. G., & Bepler, G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2091 · Cited by 333
Stereotactic radiotherapy of primary liver cancer and hepatic metastases
Wulf, J., Guckenberger, M., Haedinger, U., Oppitz, U., Mueller, G., Baier, K., & Flentje, M. (2006) · Acta Oncologica · doi:10.1080/02841860600904821 · Cited by 271
Friedel, G. (2002) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(02)00331-7 · Cited by 264
Milano, M. T., Katz, A. W., Muhs, A. G., Philip, A., Buchholz, D. J., Schell, M. C., & Okunieff, P. (2008) · Cancer · doi:10.1002/cncr.23209 · Cited by 246
Wroński, M., Arbit, E., Burt, M., & Galicich, J. H. (1995) · Journal of Neurosurgery · doi:10.3171/jns.1995.83.4.0605 · Cited by 227
Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases
Miller, G., Biernacki, P., Kemeny, N. E., Gonen, M., Downey, R., Jarnagin, W. R., D’Angelica, M., Fong, Y., Blumgart, L. H., & DeMatteo, R. P. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.04.039 · Cited by 203
Rusthoven, K. E., Hammerman, S. F., Kavanagh, B. D., Birtwhistle, M. J., Stares, M., & Camidge, D. R. (2009) · Acta Oncologica · doi:10.1080/02841860802662722 · Cited by 165
A rationale for the targeted treatment of oligometastases with radiotherapy
MacDermed, D. M., Weichselbaum, R. R., & Salama, J. K. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21102 · Cited by 118
Self-citationMehta, N. J., Mauer, A. M., Hellmän, S., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.6.1677 · Cited by 115
Self-citationKao, J., Packer, S. H., Vu, H. L., Schwartz, M., Sung, M. W., Stock, R. G., Lo, Y., Huang, D., Chen, S., & Cesaretti, J. A. (2009) · Cancer · doi:10.1002/cncr.24412 · Cited by 91
Salama, J. K., Chmura, S. J., Mehta, N., Yenice, K. M., Stadler, W. M., Vokes, E. E., Haraf, D. J., Hellmän, S., & Weichselbaum, R. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0358 · Cited by 89
Self-citationFriedel, G., Pastorino, U., Buyse, M. E., Ginsberg, R. J., Girard, P., Goldstraw, P. G., Johnston, M., McCormack, P. M. E., Pass, H. I., Putnam, J. B., et al. (1999) · PubMed · Cited by 88
Milano, M. T., Philip, A., & Okunieff, P. G. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.073 · Cited by 84
Borst, G. R., Ishikawa, M., Nijkamp, J. A., Hauptmann, M., Shirato, H., Bengua, G., Onimaru, R., Bois, A. D. J., Lebesque, J. V., & Sonke, J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.015 · Cited by 68
Cited by
Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum, R. R., Liang, H., Deng, L., & Fu, Y.-X. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.211 · Cited by 1,070
Self-citationIyengar, P., Wardak, Z., Gerber, D. E., Tumati, V., Ahn, C., Hughes, R. S., Dowell, J. E., Cheedella, N., Nedzi, L., Westover, K. D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3501 · Cited by 1,047
Stereotactic body radiotherapy for oligometastases
Tree, A. C., Khoo, V. S., Eeles, R. A., Ahmed, M., Dearnaley, D. P., Hawkins, M. A., Huddart, R. A., Nutting, C. M., Ostler, P. J., & van As, N. J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70510-7 · Cited by 524
PD-1 Restrains Radiotherapy-Induced Abscopal Effect
Park, S. S., Dong, H., Liu, X., Harrington, S. M., Krco, C. J., Grams, M. P., Mansfield, A. S., Furutani, K. M., Olivier, K. R., & Kwon, E. D. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0138 · Cited by 389
Modern radiotherapy for head and neck cancer
Alterio, D., Marvaso, G., Ferrari, A., Volpe, S., Orecchia, R., & Jereczek-Fossa, B. A. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.07.002 · Cited by 295
Metadata
- Authors
- Salama, J. K., Hasselle, M. D., Chmura, S. J., Malik, R., Mehta, N., Yenice, K. M., Villaflor, V. M., Stadler, W. M., Hoffman, P. C., Cohen, E. E. W., Connell, P. P., Haraf, D. J., Vokes, E. E., Hellman, S., & Weichselbaum, R. R.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2011-10-21
- Volume
- 118
- Issue
- 11
- Pages
- 2962-2970
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1528207664
- Cited by
- 320
- References
- 33
- FWCI
- 18.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.